Tessera
Folgen

Anniek de Ruijter

@deruijter.bsky.social

Professor of Health Law & Policy @AmsterdamLawSchool | & Law for Health and Life | Board Member @Bureau Clara Wichmann genderequality & strategic litigation | Academic Council @Amsterdam Institute for Global Health

15 Posts1561 Follower907 Folgt
Anniek de Ruijter@deruijter.bsky.social · 8mo ago

🌿new publication! 20 years after all EU health ministers adopted a resolution on the Common values of EU health systems, we ask for their reiteration and renewal in @thelancetregionaleurope🌻🌻🌻

Markus Frischhut@mrfrischhut.bsky.social · 8mo ago

Frischhut, M., Prainsack, B., Hervey, T., Ruijter, A. de, Sokol, T., Guldemond, N., Cayon-De las Cuevas, J., Exter, A. den, Fahy, N., & Oscar Fares, G. M. (2026). 20 Years of EU #healthvalues (2006–2026): four proposals for the future. @thelancet.com Regional Health - Europe. doi.org/10.1016/j.la...

Anniek de Ruijter@deruijter.bsky.social · 8mo ago

Solidarity in global genomic surveillance is not just caring, it is essential for global survival🌿 New paper in @NatureCommunications www.nature.com/articles/s41... With SimondeJong of the lab of Colin Russell at @amsterdamumc.bsky.social in the lead.

Global solidarity in genomic surveillance improves early detection of acute respiratory virus threats - Nature Communications

Respiratory virus genomic surveillance output is unevenly distributed globally. Here, the authors show that addressing this imbalance could substantially reduce the time to first detection o...

nature.com

Law Centre for Health and Life@lawhealthlife.bsky.social · last yr.

After 2 years into our existence, and proud to share our Biannual Report 2022–2024 🎉 👉 170+ publications 👉 €2.4M research funding 👉 Innovated our Master in Health Law & started a Minor in Bioethics & Law 👉 Service to society Read more: lhl.uva.nl/en/content/n... #HealthLaw #Impact #UvA

First biannual Report | Law for Health and Life (2022–2024) - LHL

Two years ago, the Law for Health and Life officially began its work as a research centre at the University of Amsterdam. We are proud to now share our first Report.

lhl.uva.nl

Anniek de Ruijter@deruijter.bsky.social · last yr.

With @PramitiParwani & @katperehudoff.bsky.social, we explored EU pharma regulators’ role in access to medicines in low-income countries. Trust remains one-way, reinforcing dependencies; building regional regulatory capacity is key for global health 💫

The Journal of Law, Medicine and Ethics@jlme-journal.bsky.social · last yr.

New open access on FirstView: "Trust Beyond Borders: European External Regulatory Influence on Access to Medicines" by Pramiti Parwani, ‪@katperehudoff.bsky.social‬, and @deruijter.bsky.social from the upcoming fall special issue "Public Health, Markets, and Law." www.cambridge.org/core/journal...

Symposium Articles Trust Beyond Borders: European External Regulatory Influence on Access to Medicines Pramiti Parwani1,2,3 , Katrina Perehudoff1,2,3 and Anniek de Ruijter1,2 1University of Amsterdam, Amsterdam Law School, Law for Health and Life, Netherlands; 2Amsterdam Institute for Global Health and Development, Netherlands and 3Amsterdam Centre for European Law and Governance, University of Amsterdam, Netherlands Abstract European institutions are widely recognized as wielding regulatory power in a globalized market, exporting its standards across borders and between sectors. This paper asks what institutional dynamics catalyze European external regulatory impact on pharmaceutical governance in low- and middle-income countries (LMICs). The research focuses on two European regulatory bodies, the European Medicines Agency (EMA) and the European Patent Office (EPO), and explores the dynamics of their technocratic outreach beyond European borders. We find that trust is a key underlying institutional dynamic facilitating some forms of European external relations. The agencies extend their influence through technical assistance, collaboration, and work-sharing with LMIC regulators, fostering a one-sided relationship of“technocratic trust.” This trust, reinforced by international regulatory frameworks that position the EMA and EPO as“trustworthy” regulators, enables these agencies to expand their regulatory influence beyond Europe. By critically examining the impact of this trust-building on LMICs’ regulatory autonomy, this research contributes to the broader discourse on European regulatory power in global health governance and highlights potential implications for pharmaceutical markets and access in LMICs. Keywords: European Regulatory Bodies; Pharmaceuticals Access; European Medicines Agency (EMA); European Patent Office (EPO); Trust
Anniek de Ruijter@deruijter.bsky.social · last yr.

Happy and proud of this recognition of our ELSA Lab AI for Health Equity with @juliavanweert.bsky.social from @lawhealthlife.bsky.social at @uvalawschool.bsky.social and so many other wonderful researchers, people, organizations and communities🌿🌿 www.uva.nl/content/nieu...

NWO-subsidie voor UvA ELSA Lab AI voor rechtvaardige zorg

De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) heeft 2,3 miljoen toegekend aan een nieuw onderzoeksinitiatief over kunstmatige intelligentie (AI) in de gezondheidszorg. Het ELSA Lab,...

uva.nl

Law Centre for Health and Life@lawhealthlife.bsky.social · 2y ago

Congratulations to Dr. @hvkolfschooten.bsky.social for successfully defending her PhD on ‘Patients’ Rights Protection and AI in Healthcare in the EU’ at UVA under the guidance of Johan Legemaate, @deruijter.bsky.social, and Kristina Irion. bit.ly/3F5Qad6

Patient Rights in the Age of AI: Hannah van Kolfschooten Defends Her PhD at the UvA - LHL

On March 6, 2025, Hannah van Kolfschooten from Law for Health and Life defended her dissertation, "Patients’ Rights Protection and Artificial Intelligence in Healthcare in the European Union."

bit.ly

Anniek de Ruijter@deruijter.bsky.social · 2y ago

Last week I spoke with @euronews.com about the potential changing role of the EU in #globalhealth as a result of the US position on the WHO www.euronews.com/health/2025/...

As the US exits the WHO, can the EU fill the gap in global health?

With Donald Trump’s plans to cut ties with the World Health Organisation (WHO), the international agency stands to lose not only $1 billion but one of the most influential actors on global health. Wil...

euronews.com

Anniek de Ruijter@deruijter.bsky.social · 2y ago

@bprainsack.bsky.social on @thelancet.bsky.social Regional Health Europe about the paper we wrote with @tamarahervey.bsky.social 🌿 On EU health politics, the European Health Union, institutional shifs (or not) and #solidarity in EU health. ✅ Podcast: www.buzzsprout.com/2223483/epis...

Anniek de Ruijter and Barbara Prainsack on solidarity in health governance and health policy in the EU - The Lancet Regional Health in conversation with

Prof. Anniek de Ruijter and Prof. Barbara Prainsack join Rafael Cardoso from The Lancet Regional Health – Europe to discuss their Personal View on solidarity and trust in EU health governance and futu...

eur04.safelinks.protection.outlook.com

Anniek de Ruijter@deruijter.bsky.social · 2y ago

Together with @martinmckee.bsky.social and @tamarahervey.bsky.social we added the outline of the missing health chapter to the Draghi report in @thelancet.bsky.social reg Europe. No productivity without strong health systems and healthy people.

Martin McKee@martinmckee.bsky.social · 2y ago

Mario Draghi’s report on productivity in the EU had a major omission - health. A healthy workforce and strong health systems are essential prerequisites. @tamarahervey.bsky.social @deruijter.bsky.social & I have provided the missing chapter www.sciencedirect.com/science/arti...